Log In
Print this Print this

RTA 801

  Manage Alerts
Collapse Summary General Information
Company Reata Pharmaceuticals Inc.
DescriptionOral superoxide dismutase 1 (SOD1) stabilizer
Molecular Target Superoxide dismutase 1 (SOD1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAmyotrophic lateral sclerosis (ALS)
Indication DetailsTreat amyotrophic lateral sclerosis (ALS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today